Cannabis 360
Second Annual Industry Conference
Cannabis 360 features industry leaders and experts covering important issues and current challenges related to cannabis and psychedelics. Cannabis 360 aims to provide key insights on the biggest opportunities within these emerging markets, both in Canada and abroad. Our speakers will provide actionable takeaways for attendees, whether you are new to the industry, or an established business searching for growth opportunities.
We encourage industry professionals—from cultivators, manufacturers, retail operators, consultants, lawyers, investors, regulators, medical professionals, scientists, and researchers —join us at the Cannabis 360 Conference to receive expert training and insights across a variety of sectors and disciplines.
EVENT FEATURES
- In-depth discussions covering key aspects of the cannabis industry
- Networking opportunity with industry professionals and experts
- Technical knowledge from industry leaders and regulatory specialists
- A virtual conference that can be accessed anywhere in the world
Expert Speakers
Our expert panelists consist of regulatory specialists, scientists, and business leaders
providing diverse perspectives on the cannabis and psychedelic industry. Our aim is to deliver valuable educational content and networking opportunities for all attendees.
-
Laleh Bighash
AAPS
President and Dean of Scientific Affairs -
Deepak Anand
Materia
Chief Executive Officer -
Lucas C. McCann
CannDelta
Co-founder & Chief Scientific Officer -
Atiyyah Ferouz
Agcann
Consulting -
Colin Bambury
Ghost Drops
Marketing Manager -
Alexzander Samuelsson
HAVN Life
Co-Founder and Chief Research Officer -
Codi Peterson
The Cannigma
Chief Science Officer -
Jenna Perry
Spiffy
Manager of Customer Success -
Patrick Moher
Microdose HQ
President -
Peter Cogan
Regis University
Associate Professor of Pharmaceutical Sciences -
Elliot Galbraith
Canna Cabana
Category Buyer -
Tabitha Fritz
Fritz’s Cannabis Company
Co-founder/CEO -
Matthew Jerome
Meristem Cannabis Consulting
Founder and Chief Consultant -
Adam Greenblatt
Cannabis Consultant -
Brian Pilecki
Clinical Psychologist -
Jeff Goldenberg
Abacus Agency
Co-founder -
Hardeep Shoker
Elevated Signals
Chief Product Officer -
Sabrina Ramkellawan
-
Chris Budd
Isolocity
Director of Sales -
Natalie Villeneuve
-
Christopher Tasker
Global Cannabinoid Solutions
Founder & CEO -
Tamara Lilien
CannSell
Head of Education -
Carl K Linn
Founder, Thai Hub of Cannabis
Author, Cannabis in Thailand -
Samantha Tabone
Chemist and Pharmaceutical Scientist -
Mark Johnson
Centricity Research
Chief Executive Officer and Medical Director -
Shahbaaz Kara-Virani
Kind
Managing Director -
Dr. Paola Cubillos
Knowde Group
Medical and Scientific Advisor
15+ Experts
Schedule
SEPTEMBER 29, 2022
Welcome Remarks
International Cannabis Markets and Business Opportunities: UK, Europe, and Asia
The international cannabis market is heating up, with new developments in countries such as Germany, Thailand, Spain, Switzerland, and the UK happening on a regular basis. As the cannabis industry matures, understanding where the biggest opportunities exist is critical. In this panel, hear from industry leaders on the recent developments happening in the key markets around the world, the different licensing processes, frameworks, and overall potential in these new markets.
Psychedelics: Market Potential and Opportunities
While psychedelics continue to gain momentum as a legitimate medical treatment, access to psychedelic therapies remains restricted in most parts of the world. Despite the difficulties in accessing psychedelic medicine, opportunities still exist from a business perspective for prospective companies looking to join this exciting new space. In this panel, learn about the different regulatory framework and licensing processes needed to start a psychedelic business, in Canada and abroad.
Empowering Your Budtenders: Education, Training and Career Advancement
Budtenders are often regarded as the driving force behind getting cannabis brands into the hands of consumers. Although the importance of budtenders is well-recognized by the industry, high turnover rates, lack of education and poor training has hampered the potential for many industry hopefuls to pursue budtending as a potential career path. Learn from industry experts on how to best support your budtenders through education and training and retain your top talent.
Psychedelic Therapy: Harm-Reduction, Risks and Ethical Concerns
As interest in the promise of psychedelic therapies continues to increase across the globe, there are concerning reports of abuse and ethical misconduct happening within psychedelic practices. As a result, there is a clear need to integrate a harm reduction approach and develop a stringent code of ethics and training programs for therapists while also acknowledging the voices of survivors raising these concerns. Panelist will cover these issues in detail and discuss how psychedelic therapy can be improved moving forward to establish safe and effective ways these substances can be integrated within a therapeutic context.
LUNCH Break
Terpenes and the Entourage Effect: Separating the Science from Marketing Buzz
The entourage effect has become widely adopted by the cannabis industry with proponents insisting that cannabinoids work along with terpenes to create certain effects associated with cannabis consumption. However, scientific evidence for the entourage effect is limited and further research is still required. In this panel, our panelist will provide a comprehensive breakdown this often-misunderstood phenomenon.
Creating Operational Efficiency Through Technology
Compliance has remained an integral part of the cannabis industry with technology evolving rapidly over the last few years to help companies reduce costs, human error, and inefficient processes within the facility. Panelist will discuss how technology can be utilized to save you time and money, move beyond traditional record keeping practice, reduce organizational risk and ensure that you always remain compliant while also improving workflow and process efficiency.
How to Create a Cannabis Brand That Resonates with Consumers
Cannabis companies have had a difficult time standing out from the myriad of brands currently available on the market. However, some brands have managed to make a significant impact, winning the hearts and minds of cannabis consumers, and establishing a strong foothold in the industry. Panelists will discuss tools and approaches to create a brand that resonates with consumers and explore innovative marketing techniques.
The Future of Clinical Trials with Psychedelics
In clinical research settings around the world, renewed investigations are taking place on the use of psychedelic substances for treating illnesses such as addiction, depression, anxiety, and posttraumatic stress disorder (PTSD). The panel of experts will briefly discuss the different phases of clinical trials, the research design process, challenges related to site selection and how they envision clinical trials with psychedelics progressing over the next several years.
Closing Remarks
10+ Companies
Our Sponsors
We are inviting a limited number of organizations to join as Sponsors of the event.
For more information or to express an interest please reach out to info@canna360.ca
If you are interested in sponsorship opportunities with Cannabis 360, contact us today!